Aveanna Healthcare Holdings Inc(AVAH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 15 at 6:40 PM ET (Korea 9/16 07:40)
Full metrics table
| Index | RUT | P/E | 11.65 | EPS (ttm) | 1.23 | Insider Own | 46.83% | Shs Outstand | 218.2M | Perf Week | 4.9% |
| Market Cap | 3.13B | Forward P/E | 15.8 | EPS next Y | 10.14% | Insider Trans | -43.86% | Shs Float | 116.1M | Perf Month | 16.31% |
| Enterprise Value | 4.54B | PEG | 0.83 | EPS next Q | 0.21 | Inst Own | 43.27% | Short Float | 4.73% | Perf Quarter | 98.2% |
| Income | 0.27B | P/S | 1.2 | EPS this Y | 37.28% | Inst Trans | 7.1% | Short Ratio | 1.94 | Perf Half Y | 108.59% |
| Sales | 2.60B | P/B | 10.88 | EPS next 5Y | 19.01% | ROA | 14.17% | Short Interest | 5.49M | Perf YTD | 75.4% |
| Book/sh | 1.32 | P/C | 32.18 | EPS past 3/5Y | - | ROE | 199.62% | 52W High | -2.48% ($14.69) | Perf Year | 70.8% |
| Cash/sh | 0.45 | P/FCF | 20.07 | Sales past 3/5Y | 10.82% 10.23% | ROIC | 17.2% | 52W Low | 141.65% ($5.93) | Perf 3Y | 923.57% |
| Dividend Est. | - | EV/EBITDA | 13.92 | EPS Y/Y TTM | 1337.9% | Gross Margin | 31.84% | Volatility(W/M) | 4.05% 4.6% | Perf 5Y | 63.96% |
| Dividend TTM | - | EV/Sales | 1.74 | Sales Y/Y TTM | 19.52% | Oper. Margin | 11.39% | ATR (14) | 0.56 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.16 | EPS Q/Q | 39.56% | Profit Margin | 10.56% | RSI (14) | 73.1 | Recom | 1.64 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.16 | Sales Q/Q | 13.73% | SMA20 | 5.51% ($13.58) | Beta | 1.93 | Target Price | $14.6 |
| Payout | - | Debt/Eq | 5.24 | Earnings | 2026/8/13 | SMA50 | 26.77% ($11.3) | Rel Volume | 1.23 | Prev Close | $14.38 |
| Employees | 35500 | LT Debt/Eq | 4.56 | EPS/Sales Surpr. | 30.72% 4.99% | SMA200 | 67.03% ($8.58) | Avg Volume(3M) | 2.82M | Price | $14.33 |
| IPO | 2021/4/29 | Option/Short | Yes/Yes | Trades | 21324 | Volume | 3,479,563 | Change | -0.35% |
Company
AVAH is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
This is a US healthcare company that provides home health and care services. It offers home-centered medical and care services, including pediatric home nursing, personalized nursing care, home visit medical care, and hospice, operating its business based on government programs and insurance. The company has established itself as a medical service provider specializing in home healthcare, including pediatric home nursing.
Over the past 1 year, on the higher side
2% below its 1-year high.
AVAH has weak earning power
11.39% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +37.3% this year.
Tap to view numbers
The price looks about right
Trading at 11.7 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +923.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 43.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHS 0.01%
LFSC 0.01%
FOXY 0.01%
SBAR 0.01%
FSEG 0.01%It ranks #4 in the industry
Based on market cap of $3B.
AVAH $3B PER 11.7
HCA $92B PER 14.2
THC $21B PER 10.1
FMS $12B PER 11.8
FAQ
What kind of company is AVAH?
AVAH belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of AVAH?
The market cap of AVAH is approximately $3.1B, ranking 1,740 within its sector.
What is the P/E ratio of AVAH?
AVAH has a P/E ratio of approximately 11.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for AVAH?
AVAH has recorded a 52-week high of $14.69 and a low of $5.93.
